Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01212874 · ClinicalTrials.gov registry record · NA
Esmolol or Nitroglycerin Infusion for Blood Pressure Control Prior to Cardiopulmonary Bypass (CPB) in Cardiac Surgery
A NA study, sponsored by Loma Linda University.
- Completed
- Registry status
- NA
- Development phase
- 70
- Enrollment target
NCT01212874 is a NA study that has completed, run by Loma Linda University. The registered enrollment target is 70 participants.
The verdict
NCT01212874, a NA study, has completed, sponsored by Loma Linda University.
- COMPLETED
- Registry status
- NA
- Development phase
- 70 participants
- Enrollment target
Study Summary
This is an investigator initiated, sponsored, open label, prospective randomized controlled trial to be performed in adult patients undergoing scheduled cardiac surgery. Patients will be randomized to esmolol infusion or nitroglycerin infusion for control of hypertension that occurs during cardiac surgery from induction of anesthesia to initiation of cardiopulmonary bypass (CPB).
Interventions
- DRUG nitroglycerin
- DRUG esmolol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2010-12 |
| Est. Completion | 2014-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01212874
The ClinicalTrials.gov registry entry for NCT01212874 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 70 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Loma Linda University, which has 237 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which nitroglycerin is the first listed.
NCT01212874 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01212874 about?
NCT01212874 is a clinical study titled "Esmolol or Nitroglycerin Infusion for Blood Pressure Control Prior to Cardiopulmonary Bypass (CPB) in Cardiac Surgery". This is an investigator initiated, sponsored, open label, prospective randomized controlled trial to be performed in adult patients undergoing scheduled cardiac surgery. Patients will be randomized to esmolol infusion or nitroglycerin infusion for control of hypertension that occurs during cardiac s...
What is the current status of trial NCT01212874?
This trial is currently completed. It is a NA study. The enrollment target is 70 participants. The study started on 2010-12. Estimated completion is 2014-06.
What interventions are being tested in trial NCT01212874?
The interventions under investigation include: nitroglycerin (DRUG), esmolol (DRUG).
Who is sponsoring clinical trial NCT01212874?
This trial is sponsored by Loma Linda University, which has 237 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.